Dystroglycan (DG) is an adhesion molecule responsible for crucial interactions between extracellular matrix and cytoplasmic compartment. It is formed by two subunits, alpha-DG (extracellular) and beta-DG (transmembrane), that bind to laminin in the matrix and dystrophin in the cytoskeleton, respectively. in this study we evaluated by Western blot analysis the expression of DG in a series of human cancer cell lines of various histogenetic origin and in a series of human primary colon and breast cancers. Decreased expression of DG was observed in most of the cell lines and in both types of tumors and correlated with higher tumor grade and stage. Analysis of the mRNA levels suggested that expression of DG protein is likely regulated at a posttranscriptional level. Evaluation of alpha-DG expression by immunostaining; in a series of archival cases of primary breast carcinomas confirmed that alpha-DG expression is lost in a significant fraction of tumors (66%). Loss of DG staining correlated with higher tumor stage (P = 0.022), positivity for p53 (P = 0.033), and high proliferation index (P = 0.045). A significant correlation Was also observed between loss of alpha-DG and overall survival (P = 0.013 by log-rank test) in an univariate analysis. These data indicate that DG expression is frequently lost in human malignancies and suggest that this glycoprotein might play an important role in human tumor development and progression.

Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression / A., Sgambato; Migaldi, Mario; M., Montanari; A., Camerini; A., Brancaccio; G., Rossi; R., Cangiano; Trentini, Giampaolo; C., Losasso; G., Capelli; A., Cittadini. - In: THE AMERICAN JOURNAL OF PATHOLOGY. - ISSN 0002-9440. - STAMPA. - 162:3(2003), pp. 849-860. [10.1016/S0002-9440(10)63881-3]

Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression

MIGALDI, Mario;TRENTINI, Giampaolo;
2003

Abstract

Dystroglycan (DG) is an adhesion molecule responsible for crucial interactions between extracellular matrix and cytoplasmic compartment. It is formed by two subunits, alpha-DG (extracellular) and beta-DG (transmembrane), that bind to laminin in the matrix and dystrophin in the cytoskeleton, respectively. in this study we evaluated by Western blot analysis the expression of DG in a series of human cancer cell lines of various histogenetic origin and in a series of human primary colon and breast cancers. Decreased expression of DG was observed in most of the cell lines and in both types of tumors and correlated with higher tumor grade and stage. Analysis of the mRNA levels suggested that expression of DG protein is likely regulated at a posttranscriptional level. Evaluation of alpha-DG expression by immunostaining; in a series of archival cases of primary breast carcinomas confirmed that alpha-DG expression is lost in a significant fraction of tumors (66%). Loss of DG staining correlated with higher tumor stage (P = 0.022), positivity for p53 (P = 0.033), and high proliferation index (P = 0.045). A significant correlation Was also observed between loss of alpha-DG and overall survival (P = 0.013 by log-rank test) in an univariate analysis. These data indicate that DG expression is frequently lost in human malignancies and suggest that this glycoprotein might play an important role in human tumor development and progression.
2003
162
3
849
860
Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression / A., Sgambato; Migaldi, Mario; M., Montanari; A., Camerini; A., Brancaccio; G., Rossi; R., Cangiano; Trentini, Giampaolo; C., Losasso; G., Capelli; A., Cittadini. - In: THE AMERICAN JOURNAL OF PATHOLOGY. - ISSN 0002-9440. - STAMPA. - 162:3(2003), pp. 849-860. [10.1016/S0002-9440(10)63881-3]
A., Sgambato; Migaldi, Mario; M., Montanari; A., Camerini; A., Brancaccio; G., Rossi; R., Cangiano; Trentini, Giampaolo; C., Losasso; G., Capelli; A.,...espandi
File in questo prodotto:
File Dimensione Formato  
Dystroglycan expression is frequently reduced in human breast and colon cancers.pdf

Accesso riservato

Tipologia: Versione dell'autore revisionata e accettata per la pubblicazione
Dimensione 425.42 kB
Formato Adobe PDF
425.42 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/306059
Citazioni
  • ???jsp.display-item.citation.pmc??? 41
  • Scopus 103
  • ???jsp.display-item.citation.isi??? 100
social impact